A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
about
Clinical immunologic approaches for the treatment of Alzheimer's diseaseImmunotherapy as treatment for Alzheimer’s diseaseCurrent Insights into Molecular Mechanisms of Alzheimer Disease and Their Implications for Therapeutic ApproachesVitamin A and Alzheimer's diseaseThe role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo.Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic miceNasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer diseasePathways towards and away from Alzheimer's diseaseImmunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease.Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryBiomarkers of Alzheimer's diseaseActive and passive immunotherapy for neurodegenerative disordersPrototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switchPassive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhageOvercoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic miceThe immunotherapy of Alzheimer's diseaseIs immunotherapy an effective treatment for Alzheimer's disease?Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic miceThe microglial "activation" continuum: from innate to adaptive responsesNovel Abeta peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease.Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein AggregationFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsAlzheimer's therapeutics: translation of preclinical science to clinical drug developmentBehavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploringPreclinical Alzheimer disease: identification of cases at risk among cognitively intact older individualsInsights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's diseaseInnate immunity in Alzheimer's disease: a complex affairTau-targeted treatment strategies in Alzheimer's diseaseInflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical diseaseAbnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's diseaseDoes neuroinflammation fan the flame in neurodegenerative diseases?Structural Correlates of Antibodies Associated with Acute Reversal of Amyloid -related Behavioral Deficits in a Mouse Model of Alzheimer DiseaseCrystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumabSpines, plasticity, and cognition in Alzheimer's model miceAlzheimer's disease: Targeting the Cholinergic SystemImmunotherapeutic approaches for Alzheimer's diseaseAmyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's diseaseActivation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils
P2860
Q22241380-63B9740B-3307-4BF8-AD13-2D1EF2251E8EQ22241491-B430D05C-F4E0-4E80-A56C-662F22ECF6DCQ22241945-4BF43002-16F1-4C47-8915-742D91C59E69Q22242414-91D49D5A-508B-4172-A1CA-C21D415A48A9Q24300901-2A64D3D0-B560-4C54-927A-3385E0D788B8Q24530682-D0904E47-C4AB-4774-A4E4-FE9B25B76649Q24534813-C8CA16AC-B39C-44B5-8D29-8D4C0E7BE5F2Q24596270-AF36B3F8-421A-4CBC-B8FD-6DCD534A330DQ24599108-3DF0E6CD-A80E-4307-B968-82D0339B2B83Q24645499-F05317BC-4957-49F4-A771-EEE5BE330FA6Q24650667-581BB9F0-7DF2-4845-81DE-1E60B39B4743Q24657879-D5183F3A-2214-491F-97D9-7B47635B9BDDQ24676179-19133CDD-7558-40E7-9500-D4D5E0309351Q24791704-55C090B6-C634-4732-A1BD-89D782BCAA9EQ24799252-1C1480D9-4401-4E18-A209-A4883F5C727FQ24804900-D3F33467-05C4-44C9-88B7-BA11A93EF326Q24804915-0F94A7F8-39AC-4923-921F-813D4A92830CQ24806882-3506FE24-B885-4CA5-9D73-986FD393EC18Q24814335-C01E155E-252F-42AC-9AAF-84C7323D8A83Q25256570-8790F93B-4922-480A-A9E1-737B4ACFA134Q26781130-59F00C9E-7485-4864-8C6A-7F0ED7582F6AQ26784569-6C01D9CB-EB02-4503-A24C-A6177512A48BQ26829267-66C41957-9C40-4EDA-A489-D3FA5DCF1F83Q26858963-C12DF823-12A6-4709-A6F1-358B2B4C2345Q26861082-609D53FC-7DD8-4C2F-8A75-40B6E3B9DE97Q26995405-C3588292-9D28-414B-948F-B30793D1F98CQ26999922-180D815A-BC8C-49CA-AD71-D3DC08A23A32Q27006944-CE5818A5-6369-418B-A765-AB043C6A1BFBQ27023429-C8CE3CAB-52D9-4351-B231-81B85FBE3CD8Q27023953-92029E16-2DAE-40B0-86B8-312E414FB371Q27314013-BFC6DC65-CFFD-44F6-904E-A0AE7C1AC754Q27349010-44E1028B-90B9-4041-824F-4CBCA88D24C8Q27498993-E9E7523E-EB67-49A8-9012-43053D88253BQ27658233-E187B23E-26C9-4E6D-8265-46667C744BEEQ27684692-49A5C706-C4E5-46F0-822F-8A8600073579Q27691328-16CB9186-6CCD-42D0-8596-462493C4AA5BQ28070135-1836E8D2-9827-411A-AEAC-8407F7B372AFQ28081278-168AAA0A-C049-4123-BC5C-3FEB9B7F0795Q28384947-981BB796-D16F-4DF1-BB9F-30AEDC718395Q28570115-80D6B500-77D3-4A9D-BC6B-44752044610D
P2860
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
A beta peptide vaccination pre ...... model of Alzheimer's disease.
@en
A beta peptide vaccination pre ...... model of Alzheimer's disease.
@nl
type
label
A beta peptide vaccination pre ...... model of Alzheimer's disease.
@en
A beta peptide vaccination pre ...... model of Alzheimer's disease.
@nl
prefLabel
A beta peptide vaccination pre ...... model of Alzheimer's disease.
@en
A beta peptide vaccination pre ...... model of Alzheimer's disease.
@nl
P2093
P356
P1433
P1476
A beta peptide vaccination pre ...... model of Alzheimer's disease.
@en
P2093
Arendash GW
Diamond DM
Gottschall PE
P2888
P304
P356
10.1038/35050116
P407
P577
2000-12-01T00:00:00Z
P6179
1050980510